EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease

Efe Doğukan Dincel iD, Faika Başoğlu-Ünal iD, Ebru Didem Kuran, Tülay Kayra, Nurcan Aydın, Esmanur Kanber, İlhami Gülçin, Nuray Ulusoy-Güzeldemirci

Chemical Biology & Drug Design · 2024-02 · 103 (2)

DOI: 10.1111/cbdd.14482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 20.02.2024. Verfasst von Efe Doğukan Dincel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Carbonic Anhydrases, Alzheimer Disease. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Istanbul Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this project, non‐sulfonamide bistrifluoromethyl‐derived hydrazide‐hydrazones were synthesized as multi‐target‐directed ligands to treat Alzheimer's disease and then, the novel derivatives were characterized by diverse spectral methods. Acetylcholinesterase (AChE), and human carbonic anhydrase (hCA) inhibitory qualifications of these compounds were determined. The reported compounds ( 2a ‐ y ) were determined to be effective inhibitors of the hCA I, hCA II and AChE enzymes with K i values in the range of 1.130 ± 0.15–5.440 ± 0.93 μM for hCA I, 0.894 ± 0.05–6.647 ± 1.35 μM for hCA II, and 0.196 ± 0.03–4.222 ± 1.04 μM for AChE. In silico studies were also performed to illuminate the binding interactions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic AnhydrasesAlzheimer DiseaseHumansAcetylcholinesteraseCarbonic Anhydrase InhibitorsCholinesterase InhibitorsHydrazonesStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

acetylcholinesterasecarbonic anhydrasehydrazide-hydrazonemolecular dockingsynthesis

Substanzen

AcetylcholinesteraseCarbonic AnhydrasesCarbonic Anhydrase InhibitorsCholinesterase InhibitorsHydrazones

Autor:innen und Institutionen

  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Istanbul University, Istanbul, Turkey.
  • Faculty of Pharmacy, Department of Pharmaceutical Chemistry, European University of Lefke, Mersin, Turkey.
  • Faculty of Science, Department of Chemistry, Atatürk University, Erzurum, Turkey.

ORCID-Profile: Efe Doğukan Dincel, Faika Başoğlu-Ünal

Förderung

  • Istanbul Üniversitesi

Zitieren

APA

Dincel, E. D., Başoğlu-Ünal, F., Kuran, E. D., Kayra, T., Aydın, N., Kanber, E., Gülçin, İ., & Ulusoy-Güzeldemirci, N. (2024). Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design, 103(2). https://doi.org/10.1111/cbdd.14482

Vancouver

Dincel ED, Başoğlu-Ünal F, Kuran ED, Kayra T, Aydın N, Kanber E, et al. Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease. Chemical Biology & Drug Design. 2024;103(2). doi:10.1111/cbdd.14482

BibTeX
@article{Dincel2024,
  author = {Dincel, Efe Doğukan and Başoğlu-Ünal, Faika and Kuran, Ebru Didem and Kayra, Tülay and Aydın, Nurcan and Kanber, Esmanur and Gülçin, İlhami and Ulusoy-Güzeldemirci, Nuray},
  title = {Design, synthesis, and evaluation of novel bistrifluoromethyl‐based hydrazones as dual inhibitors of acetylcholinesterase and carbonic anhydrase enzymes for Alzheimer's disease},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  volume = {103},
  number = {2},
  doi = {10.1111/cbdd.14482}
}
Kostenlos starten →